Clinical and Applied Thrombosis/Hemostasis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bick, R. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bick, R. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical and Applied Thrombosis/Hemostasis, Vol. 3, No. 4, 270-283 (1997)
DOI: 10.1177/107602969700300409
© 1997 SAGE Publications

The Antiphospholipid Thrombosis Syndromes: A Common Multidisciplinary Medical Problem

Rodger L. Bick, M.D., Ph.D., FACP

Clinical Professor of Medicine and Pathology; University of Texas Southwestern Medical Center and Director of the Dallas Thrombosis Hemostasis and Hematology Clinical Center Dallas, Texas, U.S.A.

Antiphospholipid antibodies are increasingly being identified as a cause of arterial and venous thrombosis as well as fetal wastage syndrome via placental vascular thrombosis. The antiphospholipid thrombosis syndromes should be considered and searched for when suggestive clinical findings are present or when unexplained arterial or venous thrombosis occurs. Noting the presence and type of antiphospholipid antibody thrombosis syndrome assumes major importance with respect to not only making an accurate diagnosis of cause of thrombosis but also in selecting effective antithrombotic therapy. The antiphospholipid thrombosis syndromes and the thrombotic and other clinical manifestations span almost all medical specialities and should be construed as a truly multidisciptinary medical problem. Key Words: Thrombosis-Anticardiolipin antibody—Lupus anticoagulant.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
R. L. Bick
State-of-the-Art Review: Antiphospholipid Thrombosis Syndromes
Clinical and Applied Thrombosis/Hemostasis, October 1, 2001; 7(4): 241 - 258.
[PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
R. L. Bick
Recurrent Miscarriage Syndrome due to Blood Coagulation Protein/Platelet Defects: Prevalence, Treatment and Outcome Results
Clinical and Applied Thrombosis/Hemostasis, July 1, 2000; 6(3): 115 - 125.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
N. Regeczy, G. Lakos, I. Balogh, E. Ajzner, E. Kiss, and G. Szegedi
State-of-the-Art-Review : The Leiden Mutation of Coagulation Factor V in Hungarian SLE Patients
Clinical and Applied Thrombosis/Hemostasis, January 1, 2000; 6(1): 41 - 45.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
R. L. Bick
Therapy for Venous Thrombosis: Guidelines for a Competent and Cost-effective Approach
Clinical and Applied Thrombosis/Hemostasis, January 1, 1999; 5(1): 2 - 9.
[PDF]